BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23002996)

  • 1. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.
    Sabino EC; Lee TH; Montalvo L; Nguyen ML; Leiby DA; Carrick DM; Otani MM; Vinelli E; Wright D; Stramer SL; Busch M;
    Transfusion; 2013 Jun; 53(6):1257-65. PubMed ID: 23002996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors.
    Buss LF; Campos de Oliveira-da Silva L; Moreira CHV; Manuli ER; Sales FC; Morales I; Di Germanio C; de Almeida-Neto C; Bakkour S; Constable P; Pinto-Filho MM; Ribeiro AL; Busch M; Sabino EC
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008787. PubMed ID: 33108390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parasitological and epidemiological aspects of Trypanosoma cruzi seropositive blood donors].
    Galaz P; García S; Mercado R; Orrego E; Pagliero B; Contreras Mdel C; Salinas P; Arancibia C
    Rev Med Chil; 2007 Oct; 135(10):1291-5. PubMed ID: 18180836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection.
    Leiby DA; Herron RM; Garratty G; Herwaldt BL
    J Infect Dis; 2008 Aug; 198(4):609-13. PubMed ID: 18588482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity.
    Sabino EC; Ribeiro AL; Lee TH; Oliveira CL; Carneiro-Proietti AB; Antunes AP; Menezes MM; Ianni BM; Salemi VM; Nastari L; Fernandes F; Sachdev V; Carrick DM; Deng X; Wright D; Gonçalez TT; Murphy EL; Custer B; Busch MP;
    Eur J Heart Fail; 2015 Apr; 17(4):416-23. PubMed ID: 25678239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.
    Custer B; Agapova M; Bruhn R; Cusick R; Kamel H; Tomasulo P; Biswas H; Tobler L; Lee TH; Caglioti S; Busch M
    Transfusion; 2012 Sep; 52(9):1901-11. PubMed ID: 22339233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors.
    Salles NA; Sabino EC; Cliquet MG; Eluf-Neto J; Mayer A; Almeida-Neto C; Mendonça MC; Dorliach-Llacer P; Chamone DF; Saéz-Alquézar A
    Transfusion; 1996; 36(11-12):969-73. PubMed ID: 8937406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of meaningful levels of Trypanosoma cruzi in platelet concentrates from seropositive blood donors.
    Cancino-Faure B; Fisa R; Riera C; Bula I; Girona-Llobera E; Jimenez-Marco T
    Transfusion; 2015 Jun; 55(6):1249-55. PubMed ID: 25683267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors.
    Tobler LH; Contestable P; Pitina L; Groth H; Shaffer S; Blackburn GR; Warren H; Lee SR; Busch MP
    Transfusion; 2007 Jan; 47(1):90-6. PubMed ID: 17207235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Trypanosoma cruzi antibody detection in eastern Andalusia (Spain).
    Marín C; Concha-Valdez F; Cañas R; Gutiérrez-Sánchez R; Sánchez-Moreno M
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):165-72. PubMed ID: 24463719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced classification of Chagas serologic results and epidemiologic characteristics of seropositive donors at three large blood centers in Brazil.
    Sabino EC; Salles NA; Sarr M; Barreto AM; Oikawa M; Oliveira CD; Leao SC; Carneiro-Proietti AB; Custer B; Busch MP;
    Transfusion; 2010 Dec; 50(12):2628-37. PubMed ID: 20576017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of Trypanosoma cruzi infection among at-risk blood donors in Japan.
    Sayama Y; Furui Y; Takakura A; Ishinoda M; Matsumoto C; Taira R; Igarashi S; Momose S; Matsubayashi K; Uchida S; Hino S; Nagai T; Satake M
    Transfusion; 2019 Jan; 59(1):287-294. PubMed ID: 30474861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disagreement between PCR and serological diagnosis of Trypanosoma cruzi infection in blood donors from a Colombian endemic region.
    García Sánchez LT; Aguilar Jiménez JR; Bueno MY; Moreno Moreno EM; Ramírez H; Daza N
    Biomedica; 2021 May; 41(Supl. 1):47-59. PubMed ID: 34111340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.
    Schijman AG; Bisio M; Orellana L; Sued M; Duffy T; Mejia Jaramillo AM; Cura C; Auter F; Veron V; Qvarnstrom Y; Deborggraeve S; Hijar G; Zulantay I; Lucero RH; Velazquez E; Tellez T; Sanchez Leon Z; Galvão L; Nolder D; Monje Rumi M; Levi JE; Ramirez JD; Zorrilla P; Flores M; Jercic MI; Crisante G; Añez N; De Castro AM; Gonzalez CI; Acosta Viana K; Yachelini P; Torrico F; Robello C; Diosque P; Triana Chavez O; Aznar C; Russomando G; Büscher P; Assal A; Guhl F; Sosa Estani S; DaSilva A; Britto C; Luquetti A; Ladzins J
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e931. PubMed ID: 21264349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries].
    Assal A; Corbi C
    Transfus Clin Biol; 2011 Apr; 18(2):286-91. PubMed ID: 21440479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi.
    Brashear RJ; Winkler MA; Schur JD; Lee H; Burczak JD; Hall HJ; Pan AA
    Transfusion; 1995 Mar; 35(3):213-8. PubMed ID: 7878713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.
    Leiby DA; Herron RM; Read EJ; Lenes BA; Stumpf RJ
    Transfusion; 2002 May; 42(5):549-55. PubMed ID: 12084162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area.
    Wincker P; Britto C; Pereira JB; Cardoso MA; Oelemann W; Morel CM
    Am J Trop Med Hyg; 1994 Dec; 51(6):771-7. PubMed ID: 7810810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.